Baton Rouge-based biopharmaceutical manufacturer TransGenRx has entered into a seven-year agreement with Novocyt to produce growth factor proteins intended for use in new human biopharmaceuticals. The…
Already an INSIDER? Sign in.
We are glad you enjoy reading Business Report.
Continue reading this story and get ACCESS to all our content from any device with a subscription now.
- Get access to more than a decade of story archives.
- Get access to our searchable data center of TOP LISTS.
- Get exclusive content only available to INSIDERS.
GET DAILY REPORT FREE

